Jen‐Chung Ko

Exploring Volatile Organic Compounds in Breath for High-Accuracy Prediction of Lung Cancer

Ping‐Hsien Tsou, Zong-Lin Lin, Yu-Chiang Pan et al. · Cancers · 2021 · 115 citations · Full text

Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells

Jen‐Chung Ko, Jyh‐Cheng Chen, Tai‐Jing Wang et al. · Biochemical Pharmacology · 2016 · 75 citations

Tumor Biology, Oncology, Mitomycin C-induced Cytotoxicity +11

Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells

Jen‐Chung Ko, Ying-Jhen Su, Szu‐Ting Lin et al. · Biochemical Pharmacology · 2009 · 69 citations

Oncogenic Agent, Medicine, Cell Death +11

Real-world experience of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma

Sheng‐Kai Liang, Min‐Shu Hsieh, Meng‐Rui Lee et al. · Oncotarget · 2017 · 63 citations · Full text

Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells

Jen‐Chung Ko, Shih‐Ci Ciou, Chao‐Min Cheng et al. · Carcinogenesis · 2008 · 59 citations

Chemotherapeutic Agents, Oncology, Tumor Microenvironment +15